Medical Consumption and Costs during a One-Year Follow-up of Patients with LUTS Suggestive of BPH in Six European Countries: Report of the TRIUMPH Study-Reference-Cited by-同舟云学术

Medical Consumption and Costs during a One-Year Follow-up of Patients with LUTS Suggestive of BPH in Six European Countries: Report of the TRIUMPH Study

Published:2006-01 Issue:1 Volume:49 Page:92-102
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

van Exel N.J.A.,Koopmanschap M.A.,McDonnell J.,Chapple C.R.,Berges R.,Rutten F.F.H.

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Lower urinary tract symptoms suggestive of benign prostatic obstruction – TRIUMPH: design and implementation;Chapple;Eur Urol,2001

2. Lower urinary tract symptoms suggestive of benign prostatic obstruction – TRIUMPH: the role of general practice databases;Logie;Eur Urol,2001

3. Impact of previously unrecognised prostatic hyperplasia on the daily activities of middle-aged and elderly men;Garraway;Br J Gen Ptact,1993

4. How do symptoms indicative of BPH progress in real life practice? The UK experience;Clifford;Eur Urol,2000

5. Benign prostatic hyperplasia in an unselected community-based population: A survey of urinary symptoms, bothersomeness and prostatic enlargement;Simpson;BJU,1996

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. α1-adrenoceptor antagonists and 5α-reductase inhibitors for urinary tract symptoms in benign prostatic hyperplasia;Journal of Paramedic Practice;2024-02-02

2. Common salt aggravated pathology of testosterone-induced benign prostatic hyperplasia in adult male Wistar rat;BMC Urology;2023-12-11

3. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial;The Lancet Regional Health - Europe;2023-08

4. Adverse events related to alpha-blockers: analysis of real-life data from Eudra-Vigilance;Minerva Urology and Nephrology;2023-08

5. Modelling ASthma TrEatment Responses (MASTER): Effect of individual patient characteristics on the risk of exacerbation in moderate or severe asthma: A time‐to‐event analysis of randomized clinical trials;British Journal of Clinical Pharmacology;2023-07-06